Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, 225001, People's Republic of China.
Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, 225001, People's Republic of China.
J Nanobiotechnology. 2022 Jun 11;20(1):271. doi: 10.1186/s12951-022-01481-y.
Circulating tumour DNA (ctDNA) has emerged as an ideal biomarker for the early diagnosis and prognosis of gastric cancer (GC). In this work, a pump-free, high-throughput microfluidic chip coupled with catalytic hairpin assembly (CHA) and hybridization chain reaction (HCR) as the signal cascade amplification strategy (CHA-HCR) was developed for surface-enhanced Raman scattering (SERS) assays of PIK3CA E542K and TP53 (two GC-related ctDNAs). The chip consisted of six parallel functional units, enabling the simultaneous analysis of multiple samples. The pump-free design and hydrophilic treatment with polyethylene glycol (PEG) realized the automatic flow of reaction solutions in microchannels, eliminating the dependence on external heavy-duty pumps and significantly improving portability. In the reaction region of the chip, products generated by target-triggered CHA initiated the HCR, forming long nicked double-stranded DNA (dsDNA) on the Au nanobowl (AuNB) array surface, to which numerous SERS probes (Raman reporters and hairpin DNA-modified CuO octahedra) were attached. This CHA-HCR strategy generated numerous active "hot spots" around the CuO octahedra and AuNB surface, significantly enhancing the SERS signal intensity. Using this chip, an ultralow limit of detection (LOD) for PIK3CA E542K (1.26 aM) and TP53 (2.04 aM) was achieved, and the whole process was completed within 13 min. Finally, a tumour-bearing mouse model was established, and ctDNA levels in mouse serum at different stages were determined. To verify the experimental accuracy, the gold-standard qRT-PCR assay was utilized, and the results showed a high degree of consistency. Thus, this rapid, sensitive and cost-effective SERS microfluidic chip has potential as an ideal detection platform for ctDNA monitoring.
循环肿瘤 DNA(ctDNA)已成为胃癌(GC)早期诊断和预后的理想生物标志物。在这项工作中,我们开发了一种无泵、高通量的微流控芯片,结合催化发夹组装(CHA)和杂交链式反应(HCR)作为信号级联放大策略(CHA-HCR),用于进行表皮生长因子受体(EGFR)T790M 和 KRAS(两种与 GC 相关的 ctDNAs)的表面增强拉曼散射(SERS)检测。该芯片由六个并行功能单元组成,能够同时分析多个样本。无泵设计和聚乙二醇(PEG)的亲水化处理实现了微通道中反应溶液的自动流动,消除了对外部重型泵的依赖,显著提高了便携性。在芯片的反应区域,靶触发的 CHA 产生的产物启动了 HCR,在 Au 纳米碗(AuNB)阵列表面形成长的缺口双链 DNA(dsDNA),大量 SERS 探针(拉曼报告分子和发夹 DNA 修饰的 CuO 八面体)附着在其上。这种 CHA-HCR 策略在 CuO 八面体和 AuNB 表面周围产生了大量的活性“热点”,显著增强了 SERS 信号强度。使用该芯片,实现了对 PIK3CA E542K(1.26 aM)和 TP53(2.04 aM)的超低检测限(LOD),整个过程在 13 分钟内完成。最后,建立了荷瘤小鼠模型,检测了不同阶段小鼠血清中的 ctDNA 水平。为了验证实验的准确性,我们使用了金标准 qRT-PCR 检测方法,结果显示出高度的一致性。因此,这种快速、灵敏且具有成本效益的 SERS 微流控芯片有望成为 ctDNA 监测的理想检测平台。